JP2024518843A5 - - Google Patents

Info

Publication number
JP2024518843A5
JP2024518843A5 JP2023571502A JP2023571502A JP2024518843A5 JP 2024518843 A5 JP2024518843 A5 JP 2024518843A5 JP 2023571502 A JP2023571502 A JP 2023571502A JP 2023571502 A JP2023571502 A JP 2023571502A JP 2024518843 A5 JP2024518843 A5 JP 2024518843A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
sequence
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518843A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/063450 external-priority patent/WO2022243378A1/en
Publication of JP2024518843A publication Critical patent/JP2024518843A/ja
Publication of JP2024518843A5 publication Critical patent/JP2024518843A5/ja
Pending legal-status Critical Current

Links

JP2023571502A 2021-05-18 2022-05-18 抗ｉｃｏｓ抗体の使用 Pending JP2024518843A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163190016P 2021-05-18 2021-05-18
US63/190,016 2021-05-18
PCT/EP2022/063450 WO2022243378A1 (en) 2021-05-18 2022-05-18 Uses of anti-icos antibodies

Publications (2)

Publication Number Publication Date
JP2024518843A JP2024518843A (ja) 2024-05-07
JP2024518843A5 true JP2024518843A5 (enExample) 2025-05-23

Family

ID=89324631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571502A Pending JP2024518843A (ja) 2021-05-18 2022-05-18 抗ｉｃｏｓ抗体の使用

Country Status (6)

Country Link
EP (1) EP4340943A1 (enExample)
JP (1) JP2024518843A (enExample)
KR (1) KR20240007760A (enExample)
CN (1) CN117460529A (enExample)
AU (1) AU2022276349A1 (enExample)
IL (1) IL308603A (enExample)

Similar Documents

Publication Publication Date Title
JP2024037894A5 (enExample)
JP2023113893A5 (enExample)
JP2024016177A5 (enExample)
JP2022510964A5 (enExample)
JP2022548947A5 (enExample)
HRP20240626T1 (hr) Bispecifična antitijela protiv ceacam5 i cd3
JP2019536806A5 (enExample)
RU2019134352A (ru) Новые биспецифические антигенсвязывающие молекулы, обладающие способностью специфически связываться с cd40 и fap
JP2020528768A5 (enExample)
RU2018145852A (ru) Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение
JP2020508317A5 (enExample)
JP2019515008A5 (enExample)
JP2020514310A5 (enExample)
JP2011506483A5 (enExample)
RU2017127772A (ru) Человеческие антитела к токсинам clostridium difficile
FI3452513T3 (fi) Humanisoituja anti-il-1r3-vasta-aineita
JP2024520666A5 (enExample)
JP2023518153A5 (enExample)
RU2019104980A (ru) Анти-icos антитела
JP2022512851A5 (enExample)
JP2024016024A5 (enExample)
JP2024533067A5 (enExample)
JP2018529661A5 (enExample)
JP2023515675A5 (enExample)
JP2023510199A5 (enExample)